John P. Lavelle, Jr.


Articles:

  • Sunday, October 1, 2006
    In January 2006, the FDA issued its much-anticipated new prescription drug labeling rule. The rule states the agency's position that FDA approval of labeling preempts many state law failure-to-warn claims. If generally adopted, the FDA's position will eliminate many of the most common tort claims attacking the labeling of prescription drugs.